Theranostics 2018; 8(4):1042-1058. doi:10.7150/thno.22557 This issue Cite

Research Paper

Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy

Jinghua Li1, Xiangyang Zu1, Gaofeng Liang1, KeKe Zhang2, Yuliang Liu2, Ke Li3, Zhong Luo3, Kaiyong Cai3✉

1. School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China;
2. School of Materials Science and Engineering, Henan University of Science and Technology, Luoyang 471023, China;
3. Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.

Citation:
Li J, Zu X, Liang G, Zhang K, Liu Y, Li K, Luo Z, Cai K. Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy. Theranostics 2018; 8(4):1042-1058. doi:10.7150/thno.22557. https://www.thno.org/v08p1042.htm
Other styles

File import instruction

Abstract

Graphic abstract

Heavy atom nanoparticles have high X-ray absorption capacity and near infrared (NIR) photothermal conversion efficiency, which could be used as radio-sensitizers. We hypothesized that concave PtCu octopod nanoframes (OPCNs) would be an efficient nanoplatform for synergistic radio-photothermal tumor ablation.

Methods: In this study, we newly exploited a folic acid-receptor (FR) mediated photothermal radiotherapy nanoagent base on OPCNs. OPCNs were synthesized with a hydrothermal method and then modified with polyethylene glycol (PEG) and folic acid (FA). A series of physical and chemical characterizations, cytotoxicity, targeting potential, endocytosis mechanism, biodistribution, systematic toxicological evaluation, pharmacokinetics, applications of OPCNs-PEG-FA for in vitro and in vivo infrared thermal imaging (ITI)/photoacoustic imaging (PAI) dual-modal imaging and synergistic photothermal radiotherapy against tumor were carried out.

Results: The OPCNs-PEG-FA demonstrated good biocompatibility, strong NIR absorption and X-ray radio-sensitization, which enabling it to track and visualize tumor in vivo via ITI/PAI dual-modal imaging. Moreover, the as-synthesized OPCNs-PEG-FA exhibited remarkable photothermal therapy (PTT) and radiotherapy (RT) synergistic tumor inhibition when treated with NIR laser and X-ray.

Conclusion: A novel multifunctional theranostic nanoplatform based on OPCNs was designed and developed for dual-modal image-guided synergistic tumor photothermal radiotherapy.

Keywords: PtCu nanoframe, targeting, near-infrared light, dual-modal imaging, synergistic tumor therapy.


Citation styles

APA
Li, J., Zu, X., Liang, G., Zhang, K., Liu, Y., Li, K., Luo, Z., Cai, K. (2018). Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy. Theranostics, 8(4), 1042-1058. https://doi.org/10.7150/thno.22557.

ACS
Li, J.; Zu, X.; Liang, G.; Zhang, K.; Liu, Y.; Li, K.; Luo, Z.; Cai, K. Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy. Theranostics 2018, 8 (4), 1042-1058. DOI: 10.7150/thno.22557.

NLM
Li J, Zu X, Liang G, Zhang K, Liu Y, Li K, Luo Z, Cai K. Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy. Theranostics 2018; 8(4):1042-1058. doi:10.7150/thno.22557. https://www.thno.org/v08p1042.htm

CSE
Li J, Zu X, Liang G, Zhang K, Liu Y, Li K, Luo Z, Cai K. 2018. Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy. Theranostics. 8(4):1042-1058.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image